Industry ranking
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2025 - 31 Dec 2025 | 28 Jan 2026 | 93 | 15% | 28% | 57% | 56% |
| 01 Jan 2025 - 31 Jul 2025 | 01 Aug 2025 | 44 | 11% | 85% | 4% | 1% |
| 01 Jul 2024 - 31 Dec 2024 | 01 Aug 2025 | 45 | 10% | 83% | 7% | 1% |
| 01 Jan 2024 - 30 Jun 2024 | 29 Jul 2024 | 44 | 6% | 89% | 5% | 2% |
| 01 Jul 2023 - 31 Dec 2023 | 12 Feb 2024 | 45 | 8% | 85% | 7% | 2% |
| 01 Jan 2023 - 30 Jun 2023 | 11 Dec 2023 | 43 | 9% | 89% | 2% | 2% |
| 01 Jul 2022 - 31 Dec 2022 | 08 Mar 2023 | 42 | 16% | 82% | 2% | 2% |
| 01 Jan 2022 - 30 Jun 2022 | 07 Mar 2023 | 39 | 23% | 76% | 1% | 2% |
| 01 Jul 2021 - 31 Dec 2021 | 07 Mar 2023 | 43 | 14% | 82% | 4% | 2% |
| 01 Jan 2021 - 30 Jun 2021 | 07 Mar 2023 | 54 | 19% | 72% | 9% | 9% |
| 01 Jun 2020 - 31 Dec 2020 | 07 Mar 2023 | 45 | 8% | 87% | 5% | 3% |
| 01 Jul 2019 - 31 Dec 2019 | 30 Jan 2020 | 42 | 18% | 79% | 3% | 2% |
| 01 Jan 2019 - 30 Jun 2019 | 30 Jul 2019 | 41 | 15% | 84% | 1% | 2% |
| 01 Jul 2018 - 31 Dec 2018 | 31 Jan 2019 | 32 | 66% | 29% | 5% | 35% |
| 01 Jan 2018 - 30 Jun 2018 | 31 Jul 2018 | 38 | 73% | 24% | 3% | 39% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
The business is currently not disclosing any General Terms and Conditions of purchase. The payment term the most commonly applied is net 30 days from the invoice date for external suppliers. Internal to Zimmer Biomet as a corporation, the longest payment term applied is 120 days from delivered good consumption.
Were there any changes to the standard payment terms in the reporting period?
During the period, purchases from intragroup subsidiaries were extended to 120 days, increased from 60 days. Consequently, the average time to make payment in the period increased to 93 days, significantly higher that prior reporting periods. The implementation of this change resulted in late payments, however, this only impacted Zimmer Biomet subsidiaries and overdue payments to third party vendors amounted to
Any other information about payment terms
During the period, payment terms from intra group suppliers were extended from 60 days to 120 days. This has resulted in an increase in average time to make payment of 93 days. The introduction of this change resulted in overdue payments being made. However, this only impacted payments to Zimmer Biomet subsidiaries and payments to third parties were unaffected.
Maximum contractual payment period agreed
120
Zimmer Biomet UK currently has no formal dispute resolution process. The suppliers are invited to contact directly the Zimmer Biomet accounts team to find a quick resolution.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Zimmer Biomet UK Limited is the UK subsidiary of Zimmer Biomet, a global medical technology group focused on orthopaedic care. The wider group designs and supplies implants and digital and robotic technologies used across the patient journey, including products for knee, hip, shoulder, foot and ankle, and sports medicine procedures, alongside data-driven tools such as ROSA robotics and mymobility. Companies House records the UK entity's nature of business as wholesale of pharmaceutical goods, reflecting its role in distributing the group's products within the UK market rather than manufacturing them itself. The company is registered in Swindon and remains active, having been incorporated in 1962.
Generated from the company's website and Companies House records. Sources: zimmer.com